These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 11363125

  • 1. Three-drug combos.
    Posit Aware; 1996; 7(1):6. PubMed ID: 11363125
    [Abstract] [Full Text] [Related]

  • 2. New double vs. triple antiviral combination study, CD4 200-500, no prior treatment.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):7. PubMed ID: 11363052
    [Abstract] [Full Text] [Related]

  • 3. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G, Pontiggia P, Orbach-Arbouys S, Triana K, Ambetima N, Morette C, Hallard M, Blanquet D.
    Biomed Pharmacother; 1996 Dec 01; 50(5):220-7. PubMed ID: 8949403
    [Abstract] [Full Text] [Related]

  • 4. 3TC approval may revive AZT's appeal.
    Vazquez E.
    Posit Aware; 1996 Dec 01; 7(1):8-9. PubMed ID: 11363136
    [Abstract] [Full Text] [Related]

  • 5. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
    James JS.
    AIDS Treat News; 1995 Dec 22; (no 237):3. PubMed ID: 11363075
    [Abstract] [Full Text] [Related]

  • 6. New combo trial/same old style.
    Gilden D.
    GMHC Treat Issues; 1995 Apr 22; 9(4):9. PubMed ID: 11362369
    [Abstract] [Full Text] [Related]

  • 7. Studies confirm value of early and combination treatments.
    Vazquez E.
    Posit Aware; 1995 Apr 22; VI(6):8. PubMed ID: 11363148
    [Abstract] [Full Text] [Related]

  • 8. AZT plus 3TC produces best results to date.
    Grodeck B.
    Posit Aware; 1995 Apr 22; ():6. PubMed ID: 11362209
    [Abstract] [Full Text] [Related]

  • 9. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS.
    AIDS Treat News; 1996 Apr 05; (no 244):6. PubMed ID: 11363307
    [Abstract] [Full Text] [Related]

  • 10. AZT studies reinforce benefits of combination.
    AIDS Alert; 1995 Jan 05; 10(1):11-2. PubMed ID: 11362167
    [Abstract] [Full Text] [Related]

  • 11. ACTG 175 and Delta.
    Torres G.
    GMHC Treat Issues; 1995 Oct 05; 9(10):2-3. PubMed ID: 11362915
    [Abstract] [Full Text] [Related]

  • 12. Protease inhibitors shine in triple combinations.
    AIDS Alert; 1996 Mar 05; 11(3):31-2. PubMed ID: 11363243
    [Abstract] [Full Text] [Related]

  • 13. HIV's Achilles' heel. Drugs and education are starting to slow the AIDS virus.
    Beardsley T.
    Sci Am; 1996 Sep 05; 275(3):16, 18. PubMed ID: 8701287
    [No Abstract] [Full Text] [Related]

  • 14. 3TC/AZT: just another combination.
    GMHC Treat Issues; 1995 Dec 05; 9(12):2. PubMed ID: 11362997
    [Abstract] [Full Text] [Related]

  • 15. Study results at a glance.
    AIDS Alert; 1995 Nov 05; 10(11):134. PubMed ID: 11362922
    [Abstract] [Full Text] [Related]

  • 16. Protease inhibitors and prevention of cross resistance.
    Levin J.
    AIDS Treat News; 1995 Oct 06; (no 232):1-3. PubMed ID: 11362875
    [Abstract] [Full Text] [Related]

  • 17. Combining d4T/ddI looks promising.
    Posit Aware; 1996 Oct 06; 7(1):7. PubMed ID: 11363129
    [Abstract] [Full Text] [Related]

  • 18. [AIDS: therapeutic changes in the second decade. Triple combination--HIV vaccination].
    Jäger H.
    Fortschr Med; 1993 May 30; 111(15):20-1. PubMed ID: 8330817
    [No Abstract] [Full Text] [Related]

  • 19. Lamivudine (3TC) approved for combination use with AZT.
    James JS.
    AIDS Treat News; 1995 Dec 01; (no 236):1-5. PubMed ID: 11363049
    [Abstract] [Full Text] [Related]

  • 20. FDA triple header. Food and Drug Administration.
    Smart T.
    GMHC Treat Issues; 1995 Nov 01; 9(11):1-3. PubMed ID: 11362986
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.